Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Intensive Diet and Exercise for Improving Knee Osteoarthritis in Obese and Overweight Older Adults

2. November 2017 aktualisiert von: Wake Forest University

Intensive Diet and Exercise for Arthritis

The purpose of this study is to compare the effects of a calorie-restricting diet, exercise, and a combination of both in reducing knee inflammation and compressive forces in obese and overweight adults with knee osteoarthritis (OA).

Studienübersicht

Status

Abgeschlossen

Bedingungen

Detaillierte Beschreibung

OA, the most common form of arthritis, occurs in about 21 million Americans. Of all the weight-bearing joints, the knee is most commonly affected by OA. Knee OA leads to physical changes to the entire joint structure, including cartilage, neighboring bone, and ligaments. Such structural changes to the knee alter joint function during movement, resulting in pain. The pain typically leads to less physical activity, leading to weight gain, followed by impaired physical function and disability.

Excessive body weight adds to the compressive forces on the knee joint and is a risk factor for OA. While there is no cure for OA, weight loss is the best nonpharmacologic way to slow OA progression. The amount of weight loss necessary to alter OA progression is unknown. The purpose of this study is to compare the effects of significant dietary restriction, exercise, and a combination of both in reducing knee inflammation and compressive forces in obese and overweight adults with knee OA. The study will also examine how diet and exercise affect everyday function and pain levels, as well as the extent of weight loss necessary for slowing OA disease progression.

This study will last 18 months. Four, 2-hour screening visits will include various questionnaires, physical exams, physical performance tests, x-rays, and blood and urine collection. Half of the participants will also undergo additional x-rays, magnetic resonance imaging (MRI), and a CT scan. Eligible participants will be randomly assigned to one of three intervention groups:

  • Group 1 participants will follow a calorie-restricted diet
  • Group 2 participants will follow an exercise regimen
  • Group 3 participants will follow a calorie-restricted diet and an exercise regimen

Group 1 and 3 participants will aim to lose at least 10% of their body weight and drop to the next lower body mass index (BMI) class level; Group 2 participants will aim to maintain their weight. Group 1 and 3 participants will follow the prescribed diet, which will include traditional healthy food and up to two meal replacement supplements. Initially, the diet will be set to result in an overall loss of 800 to 1000 calories per day. Body weight will be monitored during weekly nutritional education and behavioral sessions. For the first 6 months, Group 1 and 3 participants will attend one individual session and three group sessions per month. During Months 7 through 18, participants will attend group sessions once every two weeks and individual sessions once every 3 months. Throughout the study, participants will record food and beverage intake in daily logs that will be collected monthly.

Group 2 and 3 participants will partake in three, 60-minute exercise sessions per week for the duration of the study. The exercise sessions will incorporate aerobic exercise and resistance training. Participants will also be encouraged to exercise at home. Body weight will be monitored monthly.

Follow-up evaluations for all participants will occur at Months 6 and 18, during which most of the screening procedures will be repeated. The Month 6 follow-up will include two study visits, and the Month 18 follow-up will include three study visits. Group 2 participants will be offered dietary counseling at the end of the study.

Studientyp

Interventionell

Einschreibung (Tatsächlich)

454

Phase

  • Unzutreffend

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienorte

    • North Carolina
      • Winston-Salem, North Carolina, Vereinigte Staaten, 27109
        • Wake Forest University/Wake Forest University Forest School of Medicine

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

55 Jahre und älter (Erwachsene, Älterer Erwachsener)

Akzeptiert gesunde Freiwillige

Nein

Studienberechtigte Geschlechter

Alle

Beschreibung

Inclusion Criteria:

  • Grade II to III radiographic tibiofemoral OA of one or both knees
  • Body mass index (BMI) of 27 to 37
  • Sedentary lifestyle, defined as not participating in more than 30 minutes of formal exercise per week within the 6 months prior to study entry

Exclusion Criteria:

  • Significant comorbidity that may pose a safety risk to the participant or otherwise interfere with the study. More information about this criterion can be found in the protocol.
  • Previous acute knee injury
  • Knee injection within 1 month of study entry
  • Knee surgery within 6 months of study entry
  • Knee OA other than tibiofemoral OA
  • Unwilling or unable to change eating and physical activity habits due to environment
  • Cannot speak or read English
  • Excess alcohol use (21 or more drinks per week)
  • Unable to finish the 18-month study or unlikely to comply with the study
  • Unable to undergo MRI of the knee
  • Significant cognitive impairment

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Hauptzweck: Behandlung
  • Zuteilung: Zufällig
  • Interventionsmodell: Parallele Zuordnung
  • Maskierung: Single

Waffen und Interventionen

Teilnehmergruppe / Arm
Intervention / Behandlung
Aktiver Komparator: 1
Participants will follow an exercise regimen
The program will consist of 60-minute exercise sessions per week for the duration of the study. The exercise sessions will incorporate aerobic exercise and resistance training. Participants will also be encouraged to exercise at home.
Aktiver Komparator: 2
Participants will follow a calorie-restricted diet
The prescribed diet will include traditional healthy food and up to two meal replacement supplements. Initially, the diet will be set to result in an overall loss of 800 to 1000 calories per day.
Aktiver Komparator: 3
Participants will follow a calorie-restricted diet and an exercise regimen
The program will consist of 60-minute exercise sessions per week for the duration of the study. The exercise sessions will incorporate aerobic exercise and resistance training. Participants will also be encouraged to exercise at home.
The prescribed diet will include traditional healthy food and up to two meal replacement supplements. Initially, the diet will be set to result in an overall loss of 800 to 1000 calories per day.

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Zeitfenster
Inflammatory biomarkers
Zeitfenster: Measured at 0, 6, and 18 months (analyzed at 18 months)
Measured at 0, 6, and 18 months (analyzed at 18 months)
Knee joint loads
Zeitfenster: Measured at 0, 6, and 18 months
Measured at 0, 6, and 18 months

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Zeitfenster
Bone marrow lesions
Zeitfenster: Measured at 0 and 18 months (analyzed at 18 months)
Measured at 0 and 18 months (analyzed at 18 months)
Articular cartilage
Zeitfenster: Measured at 0 and 18 months (analyzed at 18 months)
Measured at 0 and 18 months (analyzed at 18 months)
Function
Zeitfenster: Measured at 0, 6, and 18 months
Measured at 0, 6, and 18 months
Pain
Zeitfenster: Measured at 0, 6, and 18 months
Measured at 0, 6, and 18 months
Mobility
Zeitfenster: Measured at 0, 6, and 18 months
Measured at 0, 6, and 18 months
Change in quadriceps' strength and disease progression as a function of knee alignment
Zeitfenster: Measured at 0, 6, and 18 months (analyzed at 18 months)
Measured at 0, 6, and 18 months (analyzed at 18 months)

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Ermittler

  • Hauptermittler: Stephen P. Messier, PhD, Wake Forest University, Department of Health and Exercise Science

Publikationen und hilfreiche Links

Die Bereitstellung dieser Publikationen erfolgt freiwillig durch die für die Eingabe von Informationen über die Studie verantwortliche Person. Diese können sich auf alles beziehen, was mit dem Studium zu tun hat.

Allgemeine Veröffentlichungen

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn

1. Oktober 2006

Primärer Abschluss (Tatsächlich)

1. Juni 2011

Studienabschluss (Tatsächlich)

1. Juni 2011

Studienanmeldedaten

Zuerst eingereicht

25. September 2006

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

25. September 2006

Zuerst gepostet (Schätzen)

27. September 2006

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

6. November 2017

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

2. November 2017

Zuletzt verifiziert

1. September 2011

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Andere Studien-ID-Nummern

  • R01AR052528 (US NIH Stipendium/Vertrag)
  • 1R01AR052528-01A2 (US NIH Stipendium/Vertrag)

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .

Klinische Studien zur Arthrose

3
Abonnieren